Dxcover Raises $11.9M to Advance Liquid Biopsy Platform | Business | Feb 2023
Glasgow, Scotland-based startup Dxcover has raised $11.9 million in series A and grant financing to support the development of its liquid biopsy techn
Stay updated with breaking news from Mark Bamforth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Glasgow, Scotland-based startup Dxcover has raised $11.9 million in series A and grant financing to support the development of its liquid biopsy techn
'Liquid biopsy' technique aimed at early-stage cancer diagnosis via algorithmic analysis of infrared spectra.
MEMBERS of Grassington Players recently got together to celebrate the first meeting 100 years ago of their founders.
A GLASGOW-based company developing a blood test aimed at detecting cancer at an early stage has raised £9.7 million
Enables CE Marking of blood test for brain cancer and advances colorectal cancer development Dxcover Limited, a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology